Philip H. Howe

6.4k total citations
104 papers, 5.2k citations indexed

About

Philip H. Howe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Philip H. Howe has authored 104 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 33 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Philip H. Howe's work include TGF-β signaling in diseases (27 papers), RNA modifications and cancer (19 papers) and RNA Research and Splicing (18 papers). Philip H. Howe is often cited by papers focused on TGF-β signaling in diseases (27 papers), RNA modifications and cancer (19 papers) and RNA Research and Splicing (18 papers). Philip H. Howe collaborates with scholars based in United States, France and Türkiye. Philip H. Howe's co-authors include Arindam Chaudhury, Gary Wildey, Edward B. Leof, Céline Prunier, Barbara A. Hocevar, Ge Jin, George S. Hussey, Breege V. Howley, Kumar B. Reddy and Praveen Chander and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Philip H. Howe

104 papers receiving 5.1k citations

Peers

Countries citing papers authored by Philip H. Howe

Since Specialization

Citations

This map shows the geographic impact of Philip H. Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip H. Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip H. Howe more than expected).

Fields of papers citing papers by Philip H. Howe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip H. Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip H. Howe. The network helps show where Philip H. Howe may publish in the future.

Co-authorship network of co-authors of Philip H. Howe

This figure shows the co-authorship network connecting the top 25 collaborators of Philip H. Howe. A scholar is included among the top collaborators of Philip H. Howe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip H. Howe. Philip H. Howe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The RNA-binding protein PCBP1 modulates transcription by recruiting the G-quadruplex-specific helicase DHX9 2024 ·Journal of Biological Chemistry ·(unknown), (unknown), Bidyut K. Mohanty, Annamarie C. Dalton, Toros Dincman, Viswanathan Palanisamy, Breege V. Howley, Philip H. Howe	5
2	PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness 2023 ·Cancer Biology & Therapy ·(unknown), Annamarie C. Dalton, Breege V. Howley, Philip H. Howe	4
3	Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus 2022 ·Journal of Autoimmunity ·(unknown), (unknown), Philip H. Howe, (unknown), Diane L. Kamen, Zhenwu Luo, Xiaoyu Fu, (unknown), Liuqing Yang, Xu Wang, Quan‐Zhen Li, Jim C. Oates, Weiru Zhang, David R. White, Zhuang Wan, Gary S. Gilkeson, Wei Jiang	9
4	Direct NP- A cost-effective extraction-free RT-qPCR based test for SARS-CoV-2 2022 ·Heliyon ·Rasesh Y. Parikh, Satish N. Nadig, Shikhar Mehrotra, Philip H. Howe, Vamsi K. Gangaraju	2
5	RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity 2020 ·Science Advances ·Ephraim Ansa-Addo, (unknown), Brian Riesenberg, Supinya Iamsawat, Davis Borucki, Michelle H. Nelson, Jin Hyun Nam, Dongjun Chung, Chrystal M. Paulos, Bei Liu, Xue‐Zhong Yu, Caroline C. Philpott, Philip H. Howe, Zihai Li	35
6	DSTYK Promotes Metastasis and Chemoresistance via EMT in Colorectal Cancer 2020 ·Frontiers in Pharmacology ·Jinyu Zhang, Zachary Miller, Phillip R. Musich, (unknown), Zhi Q. Yao, Qian Xie, Philip H. Howe, Yong Jiang	26
7	TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis 2019 ·Oncogene ·Alec N. Woosley, Annamarie C. Dalton, George S. Hussey, Breege V. Howley, Bidyut K. Mohanty, Simon Grelet, Toros Dincman, (unknown), Shaun K. Olsen, Philip H. Howe	69
8	PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27 2016 ·Molecular Cancer Research ·Laura A. Link, Breege V. Howley, George S. Hussey, Philip H. Howe	20
9	Post-transcriptional mapping reveals critical regulators of metastasis 2015 ·Oncoscience ·George S. Hussey, Breege V. Howley, Philip H. Howe	1
10	Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition 2013 ·Cancer Research ·Patrick Nasarre, Robert M. Gemmill, Vincent Potiron, Joëlle Roche, Xian Lu, Anna E. Barón, Christopher Korch, Elizabeth Garrett‐Mayer, Alessandro Laganà, Philip H. Howe, Harry A. Drabkin	55
11	Identification of an mRNP Complex Regulating Tumorigenesis at the Translational Elongation Step 2011 ·Molecular Cell ·George S. Hussey, Arindam Chaudhury, Andrea E. Dawson, Daniel J. Lindner, Charlotte R. Knudsen, Matthew C. J. Wilce, William C. Merrick, Philip H. Howe	157
12	Central Role for Disabled-2 in Mesenchymal Stem Cardiac Protein Expression and Functional Consequences After Engraftment in Acute Myocardial Infarction 2010 ·Stem Cells and Development ·Maritza E. Mayorga, Feng Dong, (unknown), Yanming Huang, Yong Jiang, Philip H. Howe, Marc S. Penn	9
13	Type II Transforming Growth Factor-β Receptor Recycling Is Dependent upon the Clathrin Adaptor Protein Dab2 2010 ·Molecular Biology of the Cell ·Sumedha G. Penheiter, Raman Deep Singh, Claire E. Repellin, Mark C. Wilkes, Maryanne Edens, Philip H. Howe, Richard E. Pagano, Edward B. Leof	53
14	Disabled-2 (Dab2) Is Required for Transforming Growth Factor β-induced Epithelial to Mesenchymal Transition (EMT) 2005 ·Journal of Biological Chemistry ·Céline Prunier, Philip H. Howe	109
15	Disabled-2 (Dab2) Mediates Transforming Growth Factor β(TGFβ)-stimulated Fibronectin Synthesis through TGFβ-activatedKinase 1 and Activation of the JNKPathway 2005 ·Journal of Biological Chemistry ·Barbara A. Hocevar, Céline Prunier, Philip H. Howe	98
16	The Oncoprotein Ski Acts as an Antagonist of Transforming Growth Factor-β Signaling by Suppressing Smad2 Phosphorylation 2003 ·Journal of Biological Chemistry ·Céline Prunier, Marcia Pessah, Nathalie Ferrand, Su Ryeon Seo, Philip H. Howe, Azeddine Atfi	48
17	Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells 1996 ·Nature ·Asoke K. Mal, Randy Y.C. Poon, Philip H. Howe, Hideo Toyoshima, Tony Hunter, Marian L. Harter	120
18	Oxidized low density lipoprotein and lysophosphatidylcholine stimulation of DNA synthesis in vascular smooth muscle cells appears mediated by basic fibroblast growth factor. 1995 ·Circulation ·Yuh-Cherng Chai, Philip H. Howe, (unknown), Guy Chisolm	1
19	Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. 1995 ·Journal of Clinical Investigation ·(unknown), Yoke Chin Chai, J. Fredrick Cornhill, Patrick L. Whitlow, Philip H. Howe, G M Chisolm	73
20	Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1 1994 ·Journal of Cellular Biochemistry ·Kumar B. Reddy, Barbara A. Hocevar, Philip H. Howe	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact